Star Health and Allied Insurance Company Limited
STARHEALTH
Rank in Stocks
#4498
Star Health and Allied Insurance Company Limited provides health insurance... Star Health and Allied Insurance Company Limited provides health insurance products in India. It offers retail health insurance products for individuals, families, children, senior citizens, and persons with pre-existing medical conditions; group health insurance products for employer/employee and non-employer/employee groups, including small-to-medium enterprises; and personal accident and travel insurance products. The company also provides star women care insurance policy that provides surrogacy and oocyte donor covers; and star special care product that covers children diagnosed with autism and for outpatient specialized treatments. In addition, it offers star health assure insurance policy, star cancer care platinum insurance policy, senior citizens health insurance policy, and star cardiac care insurance policy – platinum, as well as star group OPD care insurance product. The company offers its products through web aggregators, digital channels, agency channels, corporate agents, brokers, point of salesperson, insurance marketing firms, and various other channels. Star Health and Allied Insurance Company was incorporated in 2005 and is based in Chennai, India.
Share Price
$5.75
Market Cap
$3.38B
Change (1 day)
-4.03%
Change (1 year)
2.06%
Country
IN
Trade Star Health and Allied Insurance Company Limited (STARHEALTH)
Category
Financial Services
P/E ratio for Star Health and Allied Insurance Company Limited (STARHEALTH)
P/E ratio as of October 2026 TTM: 37.74
According to Star Health and Allied Insurance Company Limited latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 37.74. At the end of 2025 the company had a P/E ratio of 31.33.
P/E ratio history for Star Health and Allied Insurance Company Limited from 2013 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 37.74 | 20.46% |
| 2025 | 31.33 | -18.52% |
| 2024 | 38.44 | -20.67% |
| 2023 | 48.46 | -227.22% |
| 2022 | -38.09 | -44.87% |
| 2021 | -69.10 | -142.60% |
| 2020 | 162.21 | -49.65% |
| 2019 | 322.20 | 32.70% |
| 2018 | 242.80 | -25.87% |
| 2017 | 327.54 | 33.06% |
| 2016 | 246.16 | -212.11% |
| 2015 | -219.58 | -31.72% |
| 2014 | -321.58 | 58.51% |
| 2013 | -202.87 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 3.87 | -89.76% |
CN
|
|
| 11.94 | -68.36% |
HK
|
|
| 17.04 | -54.84% |
CA
|
|
| 13.63 | -63.89% |
TW
|
|
| 19.29 | -48.88% |
US
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.